Clinical trials
Phase 3 trials in Kazakhstan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Boehringer Ingelheim | 5 |
| AbbVie | 3 |
| Takeda | 3 |
| Bayer | 2 |
| Médecins Sans Frontières, France | 2 |
| Research Institute for Biological Safety Problems | 2 |
| Università Vita-Salute San Raffaele | 2 |
| AKARI Therapeutics | 1 |
| Altaco XXI, LLP | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis | 3 |
| Arthritis, Rheumatoid | 3 |
| Joint Diseases | 3 |
| Musculoskeletal Diseases | 3 |
| Stroke | 3 |
| Tuberculosis | 3 |
| Tuberculosis, Multidrug-Resistant | 3 |
| Bacterial Infections | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Ischemic Stroke | 2 |
Trials
Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.